Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

12.89
-0.2000-1.53%
Pre-market: 12.900.0070+0.05%04:02 EDT
Volume:1.66M
Turnover:21.51M
Market Cap:2.09B
PE:584.89
High:13.18
Open:12.98
Low:12.65
Close:13.09
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:1.26
T/O Rate:2.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:8.66
PE(LYR):290.34

Loading ...

Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $652 From $641, Maintains Buy Rating

MT Newswires Live
·
Jul 20

Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 17

Vertex’s VX-581 Dose Escalation Trial: A Fresh Signal on Cystic Fibrosis Pipeline Strength

TIPRANKS
·
Jul 17

Vertex Pharmaceuticals Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since August 2021

Dow Jones
·
Jul 15

After Crinetics’ $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?

TIPRANKS
·
Jul 15

Crinetics Pharmaceuticals (CRNX) Looks Fully Valued As Vertex Agrees $85 Per Share Deal

Simply Wall St.
·
Jul 15

Vertex to Report Q2 2026 Results After Market Close, Host Conference Call

Reuters
·
Jul 15

Vertex Minerals lifts gold sales and advances mechanised mining at Reward

TIPRANKS
·
Jul 14

Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 14

Vertex Pharmaceuticals is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 14

UBS Adjusts Vertex Pharmaceuticals Price Target to $585 From $545, Maintains Buy Rating

MT Newswires Live
·
Jul 13

BMO Capital Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jul 13

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 11

Crinetics Pharmaceuticals Announces Merger Agreement With Vertex

TIPRANKS
·
Jul 11

Vertex: Buy Rating Reaffirmed as Crinetics Deal Broadens Revenue Base; $575 Price Target Maintained

TIPRANKS
·
Jul 10

RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570

MT Newswires Live
·
Jul 10

Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Analysts Conflicted on These Healthcare Names: Certara (CERT), Nurix Therapeutics (NRIX) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jul 08

Jefferies Adjusts Vertex Pharmaceuticals Price Target to $610 From $580

MT Newswires Live
·
Jul 08

Crinetics downgraded to In Line from Outperform at Evercore ISI

TIPRANKS
·
Jul 08